We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Axes PPAR Drug Due to Safety Concerns
Roche Axes PPAR Drug Due to Safety Concerns
July 19, 2013
Roche has pulled the plug on its type 2 diabetes drug aleglitazar after safety concerns surfaced in one of its Phase III trials.